Evidence map›Paper›PMID 33067856›Full record

ArticleAddiction (Abingdon, England)2021

Evaluating the effectiveness of the smartphone app, Drink Less, compared with the NHS alcohol advice webpage, for the reduction of alcohol consumption among hazardous and harmful adult drinkers in the UK at 6-month follow-up: protocol for a randomised controlled trial.

Claire Garnett, Melissa Oldham, Colin Angus, Emma Beard, Robyn Burton, Matt Field, Felix Greaves, Matthew Hickman, Eileen Kaner, Gemma Loebenberg and 4 more

Open access · hybridAbstract readClinical Trial ProtocolLetter
In one paragraph

Article in Addiction (Abingdon, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Mobile Health Interventions for Substance Use Disorders.Annual review of clinical psychology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Claire GarnettDepartment of Behavioural Science and Health, University College London, London.ORCID 0000-0002-6589-299X
Melissa OldhamDepartment of Behavioural Science and Health, University College London, London.
Colin AngusSchool of Health and Related Research, University of Sheffield, Sheffield.ORCID 0000-0003-0529-4135
Emma BeardDepartment of Behavioural Science and Health, University College London, London.ORCID 0000-0001-8586-1261
Robyn BurtonPublic Health England, London.ORCID 0000-0003-1684-5238
Matt FieldDepartment of Psychology, University of Sheffield, Sheffield.ORCID 0000-0002-7790-5559
Felix GreavesPublic Health England, London.
Matthew HickmanBristol Population Health Science Institute, University of Bristol, Bristol.ORCID 0000-0001-9864-459X
Eileen KanerPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne.
Gemma LoebenbergDepartment of Behavioural Science and Health, University College London, London.
Susan MichieDepartment of Clinical, Educational and Health Psychology, University College London, London.
Marcus MunafòSchool of Psychological Science, University of Bristol, Bristol.ORCID 0000-0002-4049-993X
Elena PizzoDepartment of Applied Health Research, University College London, London.
Jamie BrownDepartment of Behavioural Science and Health, University College London, London.ORCID 0000-0002-2797-5428
The Behaviouralist (United Kingdom) · GBPublic Health England · GBUniversity College London · GBUniversity of Bristol · GBUniversity of Sheffield · GBNewcastle University · GB

Funding

Cancer Research UK 22962Cancer Research UK C1417/A22962Department of Health NIHR127651Medical Research Council MC_UU_00011/7Medical Research Council MR/L022206/1Medical Research Council MR/N00616X/1Medical Research Council MR/S037519/1
6 · The paper itself

Abstract

BACKGROUND AND

aimsDigital interventions are effective for reducing alcohol consumption but evidence is limited regarding smartphone apps. Drink Less is a theory- and evidence-informed app to help people reduce their alcohol consumption that has been refined in terms of its content and design for usability across the sociodemographic spectrum. We aim to evaluate the effectiveness and cost-effectiveness of recommending Drink Less at reducing alcohol consumption compared with usual digital care.

designTwo-arm individually randomised controlled trial.

settingOnline trial in the United Kingdom (UK).

participantsHazardous or harmful drinkers (Alcohol Use Disorders Identification Test [AUDIT] score ≥8) aged 18+ who want to drink less alcohol (n = 5562). Participants will be recruited from July 2020 to May 2022 using multiple strategies with a focus on remote digital methods. INTERVENTION AND COMPARATOR: Participants will be randomised to receive either an email recommending that they use Drink Less (intervention) or view the National Health Service (NHS) webpage on alcohol advice (comparator). MEASUREMENTS: The primary outcome is change in self-reported weekly alcohol consumption, assessed using the extended AUDIT-Consumption, between baseline and 6-month follow-up. Secondary outcomes include change in self-reported weekly alcohol consumption assessed at 1- and 3-month follow-ups, and the proportion of hazardous drinkers; alcohol-related problems and injury; health-related quality of life; and use of health services assessed at 6-month follow-up. Effectiveness will be examined with adjusted regression models, adjusting for baseline alcohol consumption and using an intention-to-treat approach. A mixed-methods process evaluation will assess engagement, acceptability and mechanism of action. Economic evaluations will be conducted using both a short- and longer-term time horizon. COMMENTS: This study will establish the effectiveness and cost-effectiveness of the Drink Less app at reducing alcohol consumption among hazardous and harmful adult drinkers and will be the first randomised controlled trial of an alcohol reduction app for the general population in the United Kingdom. This study will inform the decision on whether it is worth investing resources in large-scale implementation.

Indexed as

Mobile ApplicationsSmartphoneAdultAlcohol DrinkingAlcohol-Related DisordersCost-Benefit AnalysisHumansQuality of LifeRandomized Controlled Trials as TopicState MedicineUnited KingdomAlcohol reductionbehaviour changedigitalinterventionprotocolRCTsmartphone appUK

Identifiers

PMID33067856
PMCPMC8436762
OpenAlexW3093307922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.